Ping Nana, Qiu Huiying, Wang Qian, Dai Haiping, Ruan Changgeng, Ehrentraut Stefan, Drexler Hans G, MacLeod Roderick A F, Chen Suning
Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.
J Hematol Oncol. 2015 Aug 21;8:100. doi: 10.1186/s13045-015-0197-2.
Herein, we describe the establishment and characterization of the first mixed-phenotype acute leukemia cell line (JIH-5). The JIH-5 cell line was established from leukemia cells with B lymphoid/myeloid phenotype from a female mixed-phenotype acute leukemia patient. JIH-5 cells exhibit an immunophenotype comprised of myeloid and B lymphoid antigens. Whole-exome sequencing revealed somatic mutations in nine genes in JIH-5 cells. Transcriptional sequencing of JIH-5 cells identified EP300-ZNF384 fusion transcript, which is a recurrent alteration in B cell acute lymphoblastic leukemia. Our results suggest that the JIH-5 cell line may serve as a tool for the study of mixed-phenotype acute leukemia or EP300-ZNF384.
在此,我们描述了首个混合表型急性白血病细胞系(JIH-5)的建立及特征。JIH-5细胞系源自一名女性混合表型急性白血病患者具有B淋巴样/髓样表型的白血病细胞。JIH-5细胞表现出由髓样和B淋巴样抗原组成的免疫表型。全外显子组测序揭示JIH-5细胞中有9个基因发生体细胞突变。JIH-5细胞的转录测序鉴定出EP300-ZNF384融合转录本,这是B细胞急性淋巴细胞白血病中一种常见的改变。我们的结果表明,JIH-5细胞系可作为研究混合表型急性白血病或EP300-ZNF384的工具。